scholarly journals Pulmonary Hypertension Roundtable

2005 ◽  
Vol 4 (3) ◽  
pp. 26-30 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
Richard N. Channick ◽  
Ivan M. Robbins ◽  
Victor F. Tapson

In this discussion four experts shared insights on what might be considered the “gestalt” of diagnosing and monitoring pulmonary arterial hypertension. They ranged over a broad spectrum of issues that included thromboembolic pulmonary hypertension, exercise testing, hemodynamics, imaging studies, and response to therapy. The discussion was moderated by Vallerie V. McLaughlin, MD, Associate Professor of Medicine, Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan. The participants included Richard N. Channick, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Ivan M. Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee; and Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.

2004 ◽  
Vol 3 (3) ◽  
pp. 23-27
Author(s):  
Michael McGoon ◽  
Victor F. Tapson ◽  
Richard N. Channick ◽  
Valerie V. McLaughlin ◽  
Ronald J. Oudiz ◽  
...  

This discussion was moderated by Michael McGoon, MD, Professor of Medicine and Consultant in the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota. Participants included members of the Editorial Advisory Board of Advances in Pulmonary Hypertension: Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, and Editor-in-Chief of the journal; Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Vallerie V. McLaughlin, MD, Associate Professor of Medicine, Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan; Ronald J. Oudiz, MD, Associate Professor of Medicine, UCLA School of Medicine, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California; and Ivan M. Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee.


2006 ◽  
Vol 5 (4) ◽  
pp. 32-39 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
Richard N. Channick ◽  
Ivan M. Robbins ◽  
Victor F. Tapson

This discussion was moderated by Vallerie V. McLaughlin, MD, Associate Professor of Medicine and Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan. Panel members included Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Ivan M. Robbins, MD, Director of the Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee; and Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.


2004 ◽  
Vol 3 (1) ◽  
pp. 20-25
Author(s):  
Victor Tapson ◽  
Robert Frantz ◽  
John Conte

This discussion was moderated by Victor Tapson, MD, Editor-in-Chief of Advances in Pulmonary Hypertension and Associate Professor, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina. The participants included Robert Frantz, MD, Assistant Professor of Medicine, Cardiovascular Division, Mayo Clinic, Rochester, Minnesota; and John Conte, MD, Associate Professor of Surgery and Director of Heart and Lung Transplantation, Johns Hopkins University, Baltimore, MD.


2007 ◽  
Vol 6 (2) ◽  
pp. 92-95
Author(s):  
Richard Channick ◽  
Kenneth R. McCurry ◽  
Ronald Pearl ◽  
Stuart Rich

This discussion was moderated by Richard Chan-nick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. Panel members included Kenneth R. McCurry, MD, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Director, Lung and Heart-Lung Transplantation Programs, University of Pittsburgh Department of Surgery, Pittsburgh, Pennsylvania; Ronald Pearl, MD, PhD, Professor and Chair, Anesthesia Department, Stanford University School of Medicine, Stanford, California; and Stuart Rich, MD, Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, Illinois.


2005 ◽  
Vol 4 (2) ◽  
pp. 24-29
Author(s):  
Richard Channick ◽  
Hap Farber ◽  
Nicholas Hill ◽  
Robert Schilz

This discussion was moderated by Richard Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. The physicians participating included Hap Farber, MD, Director, Pulmonary Hypertension Center, Boston University Medical Center, Boston, Massachusetts; Nicholas Hill, MD, Chief, Pulmonary, Critical Care and Sleep Division, Tufts-New England Medical Center, Boston, Massachusetts; and Robert Schilz, PhD, DO, Director of Lung Transplantation and Advanced Lung Disease, and Assistant Professor of Medicine, Case Western Reserve University, Cleveland, Ohio.


2010 ◽  
Vol 9 (3) ◽  
pp. 165-169
Author(s):  
Karen A. Fagan ◽  
Nicholas Hill ◽  
Hunter Champion

Following PHA's 9th International Pulmonary Hypertension Conference and Scientific Sessions, Karen Fagan, MD, guest editor of this issue of Advances, convened a call with Nicholas Hill, MD, Chief of the Division of Pulmonary, Critical Care, and Sleep Medicine at Tufts Medical Center, Boston, and Hunter Champion, MD, PhD, associate professor of medicine in the Division of Pulmonology, Allergy and Critical Care, the Vascular Medicine Institute, and the Cardiovascular Institute at the University of Pittsburgh, to discuss their perceptions of this and past meetings and the contributions they make to progress in basic and clinical science in the care of patients with pulmonary hypertension.


2003 ◽  
Vol 2 (1) ◽  
pp. 21-25
Author(s):  
Victor F. Tapson ◽  
William Auger ◽  
Peter Fedullo ◽  
Eckhard Mayer ◽  
Christopher McGregor

Five physicians addressed important issues in the diagnosis and management of patients with pulmonary thromboembolic disease. The roundtable discussion was moderated by Victor F. Tapson, MD, Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, and included William Auger, MD, Professor of Clinical Medicine, University of California, San Diego, Medical Center, San Diego, California; Peter Fedullo, MD, Clinical Professor of Medicine, University of California, San Diego, Medical Center; Eckhard Mayer, MD, Professor of Thoracic Surgery, Department of Cardio-Thoracic Surgery, University Hospital, Mainz, Germany; and Christopher McGregor, MD, Professor of Surgery, Consultant in Cardio-Thoracic Surgery, and Director of the Mayo Clinic William J von Liebig Transplant Center, Rochester, Minnesota.


2009 ◽  
Vol 8 (3) ◽  
pp. 163-171 ◽  
Author(s):  
Nicholas Hill ◽  
Omar A. Minai ◽  
Steven Nathan

Global experts in pulmonary hypertension attended the 2009 American College of Chest Physicians meeting in San Diego. While there, Dr Nicholas Hill, Chief of the Pulmonary, Critical Care and Sleep Division, Tufts Medical Center, and Professor of Medicine, Tufts University, Boston; and Dr Steven Nathan, Medical Director, Lung Transplant and Advanced Lung Disease Program, Inova Fairfax Hospital, Falls Church, Virginia, talked with guest editor Dr Omar A. Minai to share their perspectives on current diagnosis, management, and future outlook for pulmonary hypertension patients with existing lung disease and hypoxia.


2004 ◽  
Vol 3 (2) ◽  
pp. 20-24 ◽  
Author(s):  
Ronald J. Oudiz ◽  
Michael J. Krowka ◽  
Russell Wiesner ◽  
Michael Ramsey

This discussion was moderated by Ronald J. Oudiz, MD, Associate Professor of Medicine, David Geffen School of Medicine at UCLA, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California. The participants included Michael J. Krowka, MD, Professor of Medicine, and Russell Wiesner, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, and Michael Ramsay, MD, FRCA, Chairman, Department of Anesthesiology and Pain Management, Baylor University Medical Center, and Clinical Professor, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.


2014 ◽  
Vol 12 (4) ◽  
pp. 199-205

On February 6, 2014, a group of physicians with expertise related to Chronic Thromboembolic Pulmonary Hypertension (CTEPH) met on a conference call to discuss topics related to the disease. The call was hosted by the guest editor of this issue, Richard Channick, MD, the Director of the Pulmonary Hypertension and Thromboendarterectomy Program at Massachusetts General Hospital. Dr. Channick was joined by Victor Tapson, MD, Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Duke University Medical Center and Director of the Duke Pulmonary Vascular Disease Center; Joanna Pepke-Zaba, PhD, FRCP, Lead Physician and Director, National Pulmonary Vascular Diseases Unit at the Papworth Hospital, University of Cambridge, UK; Vallerie McLaughlin, MD, Professor of Internal Medicine at the University of Michigan; and Bill Auger, MD, Professor of Clinical Medicine and Director of Academic Affairs of the PTE Program at University of California-San Diego.


Sign in / Sign up

Export Citation Format

Share Document